InsiderClue
Stocks · Health care · Surgical & Medical Instruments & Apparatus

TREACE MEDICAL CONCEPTS, INC.

TMCI Clue Score44
United States Fiscal year ends December CIK 0001630627
$3.95 +1.94% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $3.95 −84.33% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 23 Apr 2021. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2019Revenue39.4Operating income−3.5Net income−4.3Fiscal year 2020Revenue57.4 +45.5%Operating income0.9Net income−3.7EPS, diluted−0.12Fiscal year 2021Revenue94.4 +64.6%Operating income−16.5Net income−20.6EPS, diluted−0.43Fiscal year 2022Revenue141.8 +50.2%Operating income−34.8Net income−42.8EPS, diluted−0.77Fiscal year 2023Revenue187.1 +31.9%Operating income−51.4Net income−49.5EPS, diluted−0.81Fiscal year 2024Revenue209.4 +11.9%Operating income−55.7Net income−55.7EPS, diluted−0.90Fiscal year 2025Revenue212.7 +1.6%Operating income−54.2Net income−59.0EPS, diluted−0.93
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 39.4 57.4 94.4 141.8 187.1 209.4 212.7
Growth +45.5% +64.6% +50.2% +31.9% +11.9% +1.6%
Operating income −3.5 0.9 −16.5 −34.8 −51.4 −55.7 −54.2
Net income −4.3 −3.7 −20.6 −42.8 −49.5 −55.7 −59.0
Growth
EPS, diluted n/a −0.12 −0.43 −0.77 −0.81 −0.90 −0.93
Growth

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2019Gross margin80.6%Operating margin−9.0%Net margin−10.8%Free cash flow margin−22.5%Fiscal year 2020Gross margin78.3%Operating margin1.5%Net margin−6.4%Free cash flow margin−9.7%Fiscal year 2021Gross margin82.1%Operating margin−17.5%Net margin−21.8%Free cash flow margin−21.1%Fiscal year 2022Gross margin82.0%Operating margin−24.6%Net margin−30.2%Free cash flow margin−32.1%Fiscal year 2023Gross margin81.2%Operating margin−27.5%Net margin−26.5%Free cash flow margin−24.6%Fiscal year 2024Gross margin80.4%Operating margin−26.6%Net margin−26.6%Free cash flow margin−23.3%Fiscal year 2025Gross margin79.8%Operating margin−25.5%Net margin−27.7%Free cash flow margin−13.9%
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin 80.6% 78.3% 82.1% 82.0% 81.2% 80.4% 79.8%
Operating margin −9.0% 1.5% −17.5% −24.6% −27.5% −26.6% −25.5%
Net margin −10.8% −6.4% −21.8% −30.2% −26.5% −26.6% −27.7%
Free cash flow margin −22.5% −9.7% −21.1% −32.1% −24.6% −23.3% −13.9%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2019Operating cash flow−7.7Capital expenditure−1.2Free cash flow−8.9Fiscal year 2020Operating cash flow−4.5Capital expenditure−1.1Free cash flow−5.6Fiscal year 2021Operating cash flow−17.2Capital expenditure−2.7Free cash flow−19.9Fiscal year 2022Operating cash flow−30.6Capital expenditure−14.8Free cash flow−45.5Fiscal year 2023Operating cash flow−34.6Capital expenditure−11.5Free cash flow−46.0Fiscal year 2024Operating cash flow−37.2Capital expenditure−11.6Free cash flow−48.8Fiscal year 2025Operating cash flow−16.0Capital expenditure−13.5Free cash flow−29.5
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −7.7 −4.5 −17.2 −30.6 −34.6 −37.2 −16.0
Capital expenditure −1.2 −1.1 −2.7 −14.8 −11.5 −11.6 −13.5
Free cash flow −8.9 −5.6 −19.9 −45.5 −46.0 −48.8 −29.5
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2019Cash12.1Shareholders’ equity3.2Fiscal year 2020Cash18.1Total debt31.0Net cash (debt)−12.9Shareholders’ equity0.8Debt to equity39.92Fiscal year 2021Cash105.8Total debt29.4Net cash (debt)76.5Shareholders’ equity93.1Debt to equity0.32Fiscal year 2022Cash19.5Total debt52.7Net cash (debt)−33.2Shareholders’ equity60.5Debt to equity0.87Fiscal year 2023Cash13.0Total debt53.0Net cash (debt)−40.0Shareholders’ equity137.9Debt to equity0.38Fiscal year 2024Cash11.4Total debt53.3Net cash (debt)−42.0Shareholders’ equity112.9Debt to equity0.47Fiscal year 2025Cash10.7Total debt55.6Net cash (debt)−44.9Shareholders’ equity87.3Debt to equity0.64
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 12.1 18.1 105.8 19.5 13.0 11.4 10.7
Total debt n/a 31.0 29.4 52.7 53.0 53.3 55.6
Net cash (debt) n/a −12.9 76.5 −33.2 −40.0 −42.0 −44.9
Shareholders’ equity 3.2 0.8 93.1 60.5 137.9 112.9 87.3
Debt to equity n/a 39.92 0.32 0.87 0.38 0.47 0.64

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
39.4 57.4 94.4 141.8 187.1 209.4 212.7
Growth +45.5% +64.6% +50.2% +31.9% +11.9% +1.6%
7.6 12.5 16.9 25.5 35.2 41.1 42.9
31.8 44.9 77.5 116.3 151.9 168.3 169.8
Growth +41.2% +72.7% +50.0% +30.6% +10.7% +0.9%
5.1 5.8 10.2 13.6 15.4 20.6 20.3
4.5 6.5 18.4 33.0 47.0 55.7 62.7
−3.5 0.9 −16.5 −34.8 −51.4 −55.7 −54.2
Growth −2,031.0%
0.0 0.0 0.0 0.0 0.0 0.0 0.0
−4.3 −3.7 −20.6 −42.8 −49.5 −55.7 −59.0
Growth
Per share
n/a −0.12 −0.43 −0.77 −0.81 −0.90 −0.93
n/a −0.12 −0.43 −0.77 −0.81 −0.90 −0.93
Growth
n/a 37.1 48.4 55.3 60.9 62.1 63.3
n/a 37.1 48.4 55.3 60.9 62.1 63.3
Growth +30.6% +14.2% +10.1% +2.1% +1.9%

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 30.0% a year over five years.
  • The diluted share count rose 70.7% in five years, which is dilution.
  • Operating margin is down 27.0 points on five years ago, at -25.5%.
  • A net loss in 7 of 7 years on file.